Type Whole antibody Target CD44 v6 ChemSpider none | Source Humanized (from mouse) ATC code none | |
 | ||
Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.
References
Bivatuzumab mertansine Wikipedia(Text) CC BY-SA